Inventor · disambiguated record
Waleed Danho
Also filed as: DANHO WALEED
21 granted patents·7 pending applications·201 citations·filing 1987–2023
95Inventor score
Top patents by PatentIndex Score
28 records- 0189US6600015B2Selective linear peptides with melanocortin-4 receptor (MC4-R) agonist activityHOFFMANN LA ROCHE·Filed 2001·Granted Jul 29, 2003·31 cites·117 claims
- 0281US7410949B2Neuropeptide-2 receptor (Y-2R) agonists and uses thereofHOFFMANN LA ROCHE·Filed 2006·Granted Aug 12, 2008·8 cites·17 claims
- 0380US9416162B2Peptides having reduced toxicity that stimulate cholesterol effluxUNIV CALIFORNIA·Filed 2014·Granted Aug 16, 2016·3 cites·39 claims
- 0477US7642244B2Neuropeptide-2 receptor (Y-2R) agonists and uses thereofHOFFMANN LA ROCHE·Filed 2006·Granted Jan 5, 2010·4 cites·18 claims
- 0577US7045591B2Selective cyclic peptides with melanocortin-4 receptor (MC4-R) agonist activityHOFFMANN LA ROCHE·Filed 2001·Granted May 16, 2006·12 cites·76 claims
- 0673US4808701ACyclic peptides having appetite regulating activityHOFFMANN LA ROCHE·Filed 1987·Granted Feb 28, 1989·18 cites·16 claims
- 0772US11434267B2Peptides having reduced toxicity that stimulate cholesterol effluxUNIV CALIFORNIA·Filed 2020·Granted Sep 6, 2022·0 cites·13 claims
- 0871US5128448ACCK analogs with appetite regulating activityHOFFMANN LA ROCHE·Filed 1990·Granted Jul 7, 1992·30 cites·47 claims
- 0968US5182263AAnalogs of tyrosine sulfate or tyrosine phosphate containing peptidesHOFFMANN LA ROCHE·Filed 1991·Granted Jan 26, 1993·23 cites·30 claims
- 1067US10774118B2Peptides having reduced toxicity that stimulate cholesterol effluxUNIV CALIFORNIA·Filed 2018·Granted Sep 15, 2020·0 cites·26 claims
- 1166US4965343AMethod of peptide synthesisHOFFMANN LA ROCHE·Filed 1988·Granted Oct 23, 1990·18 cites·19 claims
- 1264US2008177036A1Selective Linear Peptides with Melanocortin-4 Receptor (MC4-R) Agonist ActivityCHEN LI·Filed 2008·Application pending·0 cites
- 1362US10017551B2Peptides having reduced toxicity that stimulate cholesterol effluxUNIV CALIFORNIA·Filed 2014·Granted Jul 10, 2018·0 cites·23 claims
- 1462US2024059753A1Compositions including multi-agonist peptides and methods of manufacture and usePEP2TANGO THERAPEUTICS INC·Filed 2023·Application pending·0 cites
- 1561US9023986B2Glucose-dependent insulinotropic peptide analogsDANHO WALEED·Filed 2011·Granted May 5, 2015·1 cites·41 claims
- 1661US2003229200A1Selective linear peptides with melanocor tin-4 receptor (MC4-R) agonist activityFiled 2003·Application pending·0 cites
- 1760US5508437AAnalogs of tyrosine sulfate or tyrosine phosphate containing peptidesHOFFMANN LA ROCHE·Filed 1993·Granted Apr 16, 1996·14 cites·20 claims
- 1858US2023203100A1Compositions including multi-agonist peptides and methods of manufacture and usePEP2TANGO THERAPEUTICS INC·Filed 2022·Application pending·0 cites
- 1957US2005239711A1Selective linear peptides with melanocortin-4 receptor (MC4-R) agonist activityCHEN LI·Filed 2005·Application pending·0 cites
- 2056US5013722ACholecystokinin analogs for controlling appetiteHOFFMANN LA ROCHE·Filed 1989·Granted May 7, 1991·11 cites·22 claims
- 2155US8268784B2Neuropeptide-2 receptor (Y-2R) agonists and uses thereofCONDE-KNAPE KARIN·Filed 2009·Granted Sep 18, 2012·0 cites·3 claims
- 2253US5296608AIntermediates for analogs of tyrosine sulfate or tyrosine phosphate containing peptidesHOFFMANN LA ROCHE·Filed 1992·Granted Mar 22, 1994·14 cites·15 claims
- 2352US9409961B2Cell penetrating peptides to target EIF4EHOFFMANN LA ROCHE·Filed 2013·Granted Aug 9, 2016·0 cites·14 claims
- 2451US6316593B1Synthesis of VIP analogHOFFMANN LA ROCHE·Filed 1998·Granted Nov 13, 2001·7 cites·3 claims
- 2549US6080837ASynthesis of VIP analogHOFFMANN LA ROCHE·Filed 1997·Granted Jun 27, 2000·7 cites·9 claims
- 2647US8299023B2Neuropeptide-2 receptor (Y-2R) agonistsDANHO WALEED·Filed 2009·Granted Oct 30, 2012·0 cites·5 claims
- 2747US2010179093A1Neoropeptide-2-Receptor (Y-2R) AgonistsDANHO WALEED·Filed 2009·Application pending·0 cites
- 2828US2011172147A1Neuropeptide-2 receptor (y-2r) agonistsCONDE-KNAPE KARIN·Filed 2011·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Waleed Danho files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →